Cure Parkinson’s is pleased to announce that Dr Simon Stott, current Deputy Director of Research at Cure Parkinson’s, has been promoted to the role of Director of Research.

Dr Simon Stott

Simon will lead on fostering promising new lines of research, and continue to promote beneficial worldwide scientific and clinical collaborations across the community. Simon will play a leading role in the ongoing growth of Cure Parkinson’s International Linked Clinical Trials (iLCT) programme, working alongside the iLCT Committee to ensure the most promising drugs are prioritised for clinical trial in Parkinson’s.

Simon’s promotion comes as Dr Richard Wyse, Cure Parkinson’s previous Director of Research, takes on the new role of Director of Clinical Development. Richard and Simon will continue to work closely together, as members of the Senior Leadership Team at Cure Parkinson’s.

Simon’s appointment shows the trust he has earnt from colleagues and contemporaries alike. It results from his excellent service to, commitment for and leadership of many aspects of our work. It also signals the ambition of the charity, as Cure Parkinson’s grows, to enable our innovation and funding to continue to shape the field of Parkinson’s research.

Will Cook, CEO, Cure Parkinson’s